On August 30, 2023, Cross SYNC. Inc. closed the transaction. The company has amended the terms of the transaction.

The company raised ¥510 million in the transaction. The company raised ¥230 million in its second and final tranche. The final tranche included participation from new investors Mizuho Life Science No.

1 Fund, a fund managed by Mizuho Capital Co., Ltd., Fukuda Denshi Co., Ltd., Mirai Souzou Fund, a fund managed by Mirai Souzou Capital Co., Ltd., Sony Innovation Fund, a fund managed by Sony Ventures Corporation and Innovation Growth Ventures Co., Ltd. and Yagami Manufacturing Co., Ltd. The company raised about ¥660 million till date.